From groundbreaking findings from the UK Medical Cannabis Registry to clinical trials by the industry’s leading experts, explore the latest advancements in medical cannabis research.
Cannabis Sativa L. is an extremely versatile plant that has been used for thousands of years for a ...
Rheumatic conditions such as osteoarthritis, rheumatoid arthritis, and lupus are thought to affect between 9.8% and 33.2% of ...
A growing number of countries and jurisdictions now permit the use of cannabis for medicinal – and increasingly, ...
Chronic pain is generally characterised by pain that persists for a period of three months or more. It ...
In England, most of the population access healthcare via the National Health Service (NHS). However, as waiting times ...
Eating disorders (EDs) and disordered eating have the highest mortality rate and treatment costs of all mental health ...
It is acknowledged that many mental health conditions have an onset in the first two decades of life, ...
Rheumatic and musculoskeletal diseases (RMDs) are defined as problems of the joints, muscles, and bones. It is estimated ...
Cannabis is one of the most consumed drugs globally by young people when accounting for both its medical ...
In recent years, medical cannabis – and, in particular, a highly purified cannabidiol (CBD) formulation (Epidyolex in Europe; ...
Opioid-based medications remain the most common in US clinical practice for the management of acute and chronic pain. ...
Chronic pain is estimated to affect around 20% of people worldwide – a figure that is mirrored in ...
